MedLife announced a consolidated pro-forma turnover of 3.17 billion lei in 2025, registering a growth of 17% compared to 2024. The hospital division had the largest contribution, with a 34% increase in the number of hospitalizations, reaching over 200,000. The company processed over 10 million investigations in laboratories and had nearly 5 million visits in clinics. Among the most requested services were consultations in gynecology and cardiology, as well as minimally invasive surgical interventions.
MedLife continued to expand through acquisitions, including MEDSTAR Cluj-Napoca and Routine Med Tulcea, and entered the market in the Republic of Moldova. In 2025, the company invested in technology, launching an AI assistant and inaugurating an automated laboratory. CEO Mihai Marcu emphasized the resilience of the private sector and moderate optimism for the future, mentioning that MedLife will continue to explore growth opportunities through acquisitions and the development of niche centers.
MedLife continued to expand through acquisitions, including MEDSTAR Cluj-Napoca and Routine Med Tulcea, and entered the market in the Republic of Moldova. In 2025, the company invested in technology, launching an AI assistant and inaugurating an automated laboratory. CEO Mihai Marcu emphasized the resilience of the private sector and moderate optimism for the future, mentioning that MedLife will continue to explore growth opportunities through acquisitions and the development of niche centers.
Sources
Latest News
19:00
The EU and Indonesia have signed a trade agreement and an investment protection agreement after ten years of negotiations
18:45
Nicoleta Pauliuc, removed from the leadership of the women’s organization within the PNL
18:26
Kate, Princess of Wales, will speak about her battle with cancer and recovery in a BBC documentary
18:07
Harry Kane successfully undergoes ankle surgery / Bayern's striker will be out for at least three months
17:47
AEP has ordered the confiscation of funds from all parliamentary parties over irregularities in political financing
See more news